CVL-865

· AbbVie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CVL-865, covering 2025-05-30 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures [Phase 2]